This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology
This article is within the scope of WikiProject Chemicals, a daughter project of WikiProject Chemistry, which aims to improve Wikipedia's coverage of chemicals. To participate, help improve this article or visit the project page for details on the project.ChemicalsWikipedia:WikiProject ChemicalsTemplate:WikiProject Chemicalschemicals
This article is within the scope of WikiProject Women's Health, a collaborative effort to improve the coverage of Women's Health on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.Women's HealthWikipedia:WikiProject Women's HealthTemplate:WikiProject Women's Healthwomen's health
This article has been rated as Mid-importance on the importance scale.
Possible side effects: Venous thrombosis and Meningioma
According to the German Wikipedia [^1], Chlormadinone acetate shares an increased risk of venous thromboembolism (VTE) [^2] or meningonoma (benign brain tumors). [^3]
For VTE, the estimated incidence is 6-9/10_000 (CMA group) vs. 2/10_000 (baseline) [^2]
Note that this contradicts to this version of the article, which claims "CMA does not increase the risk of venous thromboembolism."
On the other hand, it is unclear whether the German findings concerning CMA+EE are applicable to CMA alone, or whether the risk assessment might be different concerning CMA use in males. 2003:D3:8714:FA00:A60B:9C2D:84D4:F6EE (talk) 13:58, 12 May 2024 (UTC)[reply]